SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

The revenue zoomed 18.03% to Rs. 1681.83 millions for the quarter ended March 2025 as compared to Rs. 1424.93 millions during the corresponding quarter last year.The Net Profit of the company slipped to Rs. 115.74 millions from Rs. 185.97 millions, a decline of -37.76% on QoQ basis.The company reported a degrowth in operating Profit to 198.39 millions from 254.02 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202503 202403 % Var 202503 202403 % Var 202503 202403 % Var
Sales 1681.83 1424.93 18.03 6232.30 5805.50 7.35 6232.30 5805.50 7.35
Other Income -68.80 70.19 -198.02 224.77 344.22 -34.70 224.77 344.22 -34.70
PBIDT 198.39 254.02 -21.90 1239.71 1343.30 -7.71 1239.71 1343.30 -7.71
Interest 3.67 4.99 -26.45 18.83 14.63 28.71 18.83 14.63 28.71
PBDT 194.72 249.03 -21.81 1220.88 1328.67 -8.11 1220.88 1328.67 -8.11
Depreciation 32.26 26.86 20.10 128.99 106.25 21.40 128.99 106.25 21.40
PBT 162.46 222.17 -26.88 1091.89 1222.42 -10.68 1091.89 1222.42 -10.68
TAX 46.72 36.20 29.06 268.42 289.38 -7.24 268.42 289.38 -7.24
Deferred Tax -19.79 -4.93 301.42 15.15 34.95 -56.65 15.15 34.95 -56.65
PAT 115.74 185.97 -37.76 823.47 933.04 -11.74 823.47 933.04 -11.74
Equity 200.30 200.30 0.00 200.30 200.30 0.00 200.30 200.30 0.00
PBIDTM(%) 11.80 17.83 -33.83 19.89 23.14 -14.03 19.89 23.14 -14.03

Lincoln Pharma Share Price

645.00 -0.40 (-0.06%)
04-May-2026 11:43 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1821.00
Dr. Reddys Lab 1303.55
Cipla 1325.25
Zydus Lifesciences 900.70
Lupin 2347.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×